FASN and cancer: Some studies have reported that inhibiting cancer cell fatty acid availability can suppress cellular proliferation by targeting key lipogenesis-related enzymes such as fatty acid synthase (FASN) and acetyl-CoA carboxylase1 (ACC1) [17–23].